Under construction – not a live service
Sign in

2023-503270-20-00CompletedPhase 1

Randomized, non-comparative, open-label early phase Ib study with OBT076 or OBT076 followed by Balstilimab in patients with Adenoid Cystic Carninoma of the Head and Neck

Source: EU CTIS (euclinicaltrials.eu) · Last updated 3 Jun 2024

Next steps

Status (registry)
Completed
Phase (registry)
Phase 1
Study type
Interventional
Enrollment
32 (actual)
First submitted
21 Apr 2023
Start date
29 Nov 2023
Lead sponsor
Groupe Oncologie Radiotherapie Tete Cou
EU CT number
2023-503270-20-00

What you commit to

  • Study type: Interventional · Phase 1
  • Participants enrolled: 32
  • 16 sites in 1 country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of EU CTIS (euclinicaltrials.eu). It describes the study design.

Sites (16)

Sites in registry order. Save your city in your profile to sort them by distance.

SiteCityCountrySite status
Institut Sainte-CatherineAvignonFranceCompleted
Centre hospitalier Universitaire de BordeauxBordeauxFranceCompleted
Centre Francois BaclesseCaen Cedex 5FranceCompleted
Centre Jean PerrinClermont-FerrandFranceCompleted
Centre Oscar LambretLilleFranceCompleted
Centre Leon BerardLyonFranceCompleted
Assistance Publique Hôpitaux de MarseilleMarseilleFranceCompleted
Institut Regional Du Cancer De MontpellierMontpellier Cedex 5FranceCompleted
Centre Antoine LacassagneNice Cedex 2FranceCompleted
Centre Hospitalier Lyon-SudPierre-BéniteFranceCompleted
Institut De Cancerologie De L OuestSt HerblainFranceCompleted
Institut de Cancérologie Strasbourg EuropeStrasbourgFranceCompleted
Institut Claudius RegaudToulouseFranceCompleted
Centre Hospitalier Regional Universitaire De ToursTours Cedex 9FranceCompleted
Institut de cancérologie de LorraineVandoeuvre Les Nancy_ CedexFranceCompleted
Institut Gustave RoussyVillejuifFranceCompleted

Are you the coordinator? Confirm the details

This page is information, not medical advice. Discuss any trial with your doctor.